Does pretreatment neutrophil-to-lymphocyte ratio predict prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy?
Pretreatment NLR may be an independent prognostic factor for mRCC patients who are receiving targeted therapy.
CSA improves the nuclear entry of core protein. The increase of HBcAg in nucleus was likely to be related with it's phosphorylation and cell aging or apoptosis.